Back
Uranium Energy Corp. 10K Form
Buy
52
UEC
Uranium Energy Corp.
Last Price:
$14.19
Seasonality Move:
17.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-06-10 | 10Q | UEC/Uranium Energy Corp. Quarterly |
| 2024-03-11 | 10Q | UEC/Uranium Energy Corp. Quarterly |
| 2023-12-11 | 10Q | UEC/Uranium Energy Corp. Quarterly |
| 2023-06-09 | 10Q | UEC/Uranium Energy Corp. Quarterly |
| 2023-03-13 | 10Q | UEC/Uranium Energy Corp. Quarterly |
| 2022-12-19 | 10Q | UEC/Uranium Energy Corp. Quarterly |
Receive UEC News And Ratings
See the #1 stock for the next 7 days that we like better than UEC
UEC Financial Statistics
Sales & Book Value
| Annual Sales: | $66.8M |
|---|---|
| Cash Flow: | $-204.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.17 |
| Price / Book: | 6.36 |
Profitability
| EPS (TTM): | -0.20460 |
|---|---|
| Net Income (TTM): | $-87.7M |
| Gross Margin: | $-46.1M |
| Return on Equity: | -10.06% |
| Return on Assets: | -8.92% |
Uranium Energy Corp. Earnings Forecast
Key Uranium Energy Corp. Financial Ratios
-
The Gross Profit Margin over the past 22 years for UEC is -68.92%.
-
The Selling, General & Administrative Expenses for UEC have been equal to 40.79% of Gross Profit Margin.
-
The Net Earning history of UEC is -131.15% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 12 years.
Uranium Energy Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | UEC |
| CUSIP: | 916896 |
| Website: | uraniumenergy.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 8.85 |
| Quick Ratio: | 5.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 71.94 |
UEC Technical Analysis vs Fundamental Analysis
Buy
52
Uranium Energy Corp. (UEC)
is a Buy
Is Uranium Energy Corp. a Buy or a Sell?
-
Uranium Energy Corp. stock is rated a BuyThe current Uranium Energy Corp. [UEC] share price is $14.18. The Score for UEC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.